Increased flow is a reported side effect, particularly during the first few months of metabolic rebalancing
However, it significantly affects metabolic markers
Currently, five other synthetic drugs as well as one biological semaglutide drug are being reviewed by the Agency
(2011) "Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function" Journal of Diabetes Research, 2011:279530 This article was reviewed and approved by Alice Fletcher, Lead Bariatric Dietician, and Lujain Alhassan, Bariatric Nutritionist, on 20 May 2025
The GLP-1 sequence is highly conserved between the species, with no sequence variation occurring in mammals
Your order may ship in multiple packages to ensure they reach you as soon as possible